These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18035143)

  • 1. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
    Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
    J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.
    Kim ES; Kim EK; Choi CW; Kim HS; Kim BI; Choi JH; Park JS; Moon KC
    J Pediatr; 2010 Nov; 157(5):745-50.e1. PubMed ID: 20598319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome.
    Seyberth HW; Müller H; Wille L; Plückthun H; Wolf D; Ulmer HE
    Pediatr Pharmacol (New York); 1982; 2(2):127-41. PubMed ID: 12760405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of ductal closure and intestinal complications in very low birth weight infants treated with indomethacin.
    Madan J; Fiascone J; Balasubramanian V; Griffith J; Hagadorn JI
    Neonatology; 2008; 94(1):45-51. PubMed ID: 18196930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    Clyman RI; Brett C; Mauray F
    Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors associated with the patency of ductus arteriosus in preterm infants with respiratory distress syndrome in Kuwait.
    Hammoud MS; Elsori HA; Hanafi EA; Shalabi AA; Fouda IA; Devarajan LV
    Saudi Med J; 2003 Sep; 24(9):982-5. PubMed ID: 12973483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indomethacin and persistent ductus arterious in the pre-term newborn infant with respiratory insufficiency].
    Hurtado del Río D; Holden Barker AM; Segura MA; Lozano González C
    Arch Inst Cardiol Mex; 1981; 51(1):83-8. PubMed ID: 7212861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin therapy in premature infants of advanced postnatal age.
    Achanti B; Pyati S; Yeh TF
    J Perinatol; 1987; 7(3):235-7. PubMed ID: 3504463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant.
    Strauss A; Modanlou HD; Gyepes M; Wittner R
    Am J Dis Child; 1982 Oct; 136(10):934-6. PubMed ID: 6889810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus.
    Lilien LD; Srinivasan G; Yeh TF; Pildes RS
    Pediatr Pharmacol (New York); 1985; 5(1):73-7. PubMed ID: 3887313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early closure of ductus arteriosus with indomethacin].
    Kääpä P
    Klin Padiatr; 1985; 197(2):172. PubMed ID: 3990156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.
    Chorne N; Leonard C; Piecuch R; Clyman RI
    Pediatrics; 2007 Jun; 119(6):1165-74. PubMed ID: 17545385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.
    Noori S; McCoy M; Friedlich P; Bright B; Gottipati V; Seri I; Sekar K
    Pediatrics; 2009 Jan; 123(1):e138-44. PubMed ID: 19117835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patency of ductus arteriosus in the premature newborn infant: diagnosis, complications, treatment].
    Agnetti A; Viola P; Zavota L; De Luca F; Squarcia U
    Pediatr Med Chir; 1984; 6(5):609-15. PubMed ID: 6535121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams.
    Barefield ES; Dwyer MD; Cassady G
    J Perinatol; 1993; 13(5):376-80. PubMed ID: 8263622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.